Celltrion | 068270 - Pre Tax Profit

Stock Price
201,500.00
Daily Change
-500.00 -0.25%
Monthly
-2.18%
Yearly
22.72%
Q2 Forecast
184,597.56

Celltrion reported KRW14.6B in Pre-Tax Profit for its fiscal quarter ending in June of 2025.





Pre Tax Profit Change Date
Akebia Therapeutics USD -11.24M 12.39M Dec/2025
Alaunos Therapeutics USD -7.84M 633K Dec/2023
Avita Medical AUD -11.64M 12.13M Dec/2025
Celltrion KRW 14.6B 180.89B Jun/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Ionis Pharmaceuticals USD -228M 99M Dec/2025
IQVIA Holdings USD 6.16B 5.84B Sep/2025
Moderna USD -187M 631M Sep/2025
Organon & Co USD 243M 14M Sep/2025
Revvity USD 55.68M 115.97M Sep/2025
Tectonic Therapeutic USD -18.97M 63K Dec/2025
Viatris USD -7.9M 209.2M Sep/2025
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025